Cooper Odelia
Pituitary Center, Division of Endocrinology, Diabetes and Metabolism, Cedars-Sinai Medical Center, 127 S. San Vicente Blvd, A6600, Los Angeles, CA, 90048, USA.
Pituitary. 2025 May 17;28(3):60. doi: 10.1007/s11102-025-01535-y.
Posterior pituitary tumors (PPT) are rare, benign tumors but may lead to compromised hypothalamic and pituitary function. A new study by Kremenevski et al. presents a single institution experience of these tumors, namely, pituicytomas, spindle cell oncocytomas, and granular cell tumors. They incorporate the revised 2022 WHO classification and highlight the preoperative and postoperative endocrine, metabolic, and radiologic outcomes of PPT. This study adds to our knowledge in this rare subset of tumors and underscores the need for ongoing surveillance for hypopituitarism and hypothalamic obesity.
垂体后叶肿瘤（PPT）是罕见的良性肿瘤，但可能导致下丘脑和垂体功能受损。克雷梅涅夫斯基等人的一项新研究展示了这些肿瘤（即垂体细胞瘤、梭形细胞嗜酸性细胞瘤和颗粒细胞瘤）在单一机构的治疗经验。他们纳入了2022年世界卫生组织修订的分类，并强调了垂体后叶肿瘤术前和术后的内分泌、代谢及影像学结果。这项研究增加了我们对这一罕见肿瘤亚型的认识，并强调了对垂体功能减退和下丘脑性肥胖进行持续监测的必要性。
